ICON Lenexa

Lenexa, Kansas 66219-9746

1 studies enrolling now · 12 studies all time

What they study most

APOL1-mediated Kidney Disease, Alpha 1-Antitrypsin Deficiency, Alpha-1 Antitrypsin Deficiency, Attention Deficit Disorder With Hyperactivity, Autosomal Dominant Polycystic Kidney Disease (ADPKD), COVID-19, Healthy Volunteers, Pain

Studies at this site

• A Study to Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of Xanomeline Following KarXT Administration in Healthy Adult Participants — Recruiting now
• A Phase 1 Study Evaluating Safety, Tolerability, and Pharmacokinetics of VX-407 in Healthy Participants — Completed
• A Trial to Characterize Differences in Blood Levels of Different Lots of Centanafadine QD XR and to Understand the Effect of Food on Blood Levels — Completed
• A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of VX-407 in Healthy Participants — Completed
• A Phase 1 Dose Escalation Study of Intravenous VX-993 in Healthy Adults — Completed
• A Drug-drug Interaction Study of S-892216 Coadministered With Carbamazepime to Healthy Adult Participants — Completed
• A Study to Investigate Different Formulations of S-337395 in Healthy Adult Participants — Completed
• A Study to Evaluate the Effect of VX-548 on the QT/QTc Interval in Healthy Participants — Completed
• A Phase 1, First-in-human Study of VX-668 — Completed
• A Phase 1, First-in-human Study of VX-634 — Completed
• A Study to Assess the Effect of BMS-986419 on the Single Dose Drug Levels of Probe Substrates in Healthy Participants — Completed
• A Phase 1 Dose Escalation Study to Evaluate Safety and Pharmacokinetics (PK) of VX-840 in Healthy Participants — Completed